State Street
LTRN icon

State Street’s Lantern Pharma LTRN Stock Holding History

State Street’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.6K Hold
23,652
– – ﹤0.01% 3972
2026
Q1 		$32.4K Hold
23,652
– – ﹤0.01% 4178
2025
Q4 		$71.7K Hold
23,652
– – ﹤0.01% 4106
2025
Q3 		$103K Hold
23,652
– – ﹤0.01% 4050
2025
Q2 		$74.7K Hold
23,652
– – ﹤0.01% 4028
2025
Q1 		$83.7K Hold
23,652
– – ﹤0.01% 4004
2024
Q4 		$75.5K Hold
23,652
– – ﹤0.01% 4048
2024
Q3 		$86.8K Hold
23,652
– – ﹤0.01% 4003
2024
Q2 		$110K Sell
23,652
-1,400
-6% -$8.42K ﹤0.01% 3981
2024
Q1 		$220K Sell
25,052
-2,700
-10% -$14.4K ﹤0.01% 3854
2023
Q4 		$119K Hold
27,752
– – ﹤0.01% 4026
2023
Q3 		$94.6K Hold
27,752
– – ﹤0.01% 4126
2023
Q2 		$157K Hold
27,752
– – ﹤0.01% 4080
2023
Q1 		$134K Hold
27,752
– – ﹤0.01% 4223
2022
Q4 		$168K Hold
27,752
– – ﹤0.01% 4178
2022
Q3 		$133K Hold
27,752
– – ﹤0.01% 4328
2022
Q2 		$158K Hold
27,752
– – ﹤0.01% 4312
2022
Q1 		$198K Buy
27,752
+2,185
+9% +$14.6K ﹤0.01% 4388
2021
Q4 		$204K Hold
25,567
– – ﹤0.01% 4341
2021
Q3 		$286K Buy
+25,567
New +$331K ﹤0.01% 4223

Other funds holding LTRN

EAM
Empery Asset Management New York $86.5M AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

State Street's LTRN Position: Q2 2026 in Review

State Street held its Lantern Pharma (LTRN) position steady in Q2 2026 at 23,652 shares worth $98.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3972.

State Street first reported a position in LTRN in Q3 2021 and has held it in 20 quarters since. The position peaked at $286K in Q3 2021. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • State Street held 23,652 shares of Lantern Pharma worth $98.6K as of Q2 2026.
  • State Street left its Lantern Pharma share count unchanged in Q2 2026.
  • Lantern Pharma made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3972 holding.
  • State Street first reported a position in Lantern Pharma in Q3 2021 and has held it in 20 quarters since.
  • State Street's Lantern Pharma position peaked at $286K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.